DekaBank Deutsche Girozentrale - AMICUS THERAPEUTICS INC ownership

AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 240 filers reported holding AMICUS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of AMICUS THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$2,135
-16.7%
217,7000.0%0.00%
-20.0%
Q1 2024$2,563
-19.3%
217,7000.0%0.01%
-28.6%
Q4 2023$3,175
+23.0%
217,7000.0%0.01%
+16.7%
Q3 2023$2,581
-5.5%
217,7000.0%0.01%0.0%
Q2 2023$2,731
+17.1%
217,7000.0%0.01%0.0%
Q1 2023$2,333
-9.9%
217,7000.0%0.01%
-14.3%
Q4 2022$2,590
-99.9%
217,7000.0%0.01%
+16.7%
Q3 2022$2,195,000
-4.5%
217,7000.0%0.01%
-14.3%
Q2 2022$2,298,000
+144.7%
217,700
+122.8%
0.01%
+250.0%
Q1 2022$939,000
-11.2%
97,700
+10.0%
0.00%
-33.3%
Q4 2021$1,058,000
+23.7%
88,800
+2.9%
0.00%
+50.0%
Q3 2021$855,0000.0%86,3000.0%0.00%0.0%
Q2 2021$855,000
+6.1%
86,3000.0%0.00%
-33.3%
Q1 2021$806,000
-58.5%
86,3000.0%0.00%
-57.1%
Q4 2020$1,943,000
-12.6%
86,300
-46.3%
0.01%
-30.0%
Q3 2020$2,223,000
+132.3%
160,600
+35.4%
0.01%
+66.7%
Q3 2019$957,000
-67.4%
118,600
-51.5%
0.01%
-60.0%
Q2 2019$2,935,000
+222.9%
244,600
+266.2%
0.02%
+200.0%
Q1 2019$909,000
+12.2%
66,800
-23.5%
0.01%0.0%
Q4 2018$810,000
-10.9%
87,300
+30.7%
0.01%0.0%
Q3 2018$909,000
-14.4%
66,800
-2.5%
0.01%
-28.6%
Q2 2018$1,062,000
+5.6%
68,500
-1.4%
0.01%0.0%
Q1 2018$1,006,000
+12.7%
69,500
-2.0%
0.01%0.0%
Q4 2017$893,0000.0%70,9000.0%0.01%0.0%
Q3 2017$893,000
+26.8%
70,9000.0%0.01%
+16.7%
Q2 2017$704,000
+37.8%
70,9000.0%0.01%
+20.0%
Q1 2017$511,000
+38.1%
70,900
-7.8%
0.01%
+25.0%
Q4 2016$370,000
-26.1%
76,900
+8.5%
0.00%
-33.3%
Q3 2016$501,000
+30.5%
70,9000.0%0.01%
+50.0%
Q2 2016$384,000
-10.9%
70,900
+31.5%
0.00%
-20.0%
Q1 2016$431,000
-25.9%
53,900
-10.8%
0.01%
-28.6%
Q4 2015$582,000
-30.0%
60,400
+1.7%
0.01%
-30.0%
Q3 2015$831,000
+26.3%
59,400
+27.7%
0.01%
+25.0%
Q2 2015$658,000
+35.1%
46,500
+3.8%
0.01%
+33.3%
Q1 2015$487,000
+637.9%
44,800
+57.2%
0.01%
+500.0%
Q4 2013$66,000
+3.1%
28,500
+3.6%
0.00%0.0%
Q3 2013$64,000
+6.7%
27,500
+5.8%
0.00%0.0%
Q2 2013$60,00026,0000.00%
Other shareholders
AMICUS THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 1,315,395$30,372,00010.86%
Palo Alto Investors LP 7,867,114$181,652,0009.52%
Perceptive Advisors 25,112,048$579,837,0006.22%
Redmile Group, LLC 20,620,490$476,127,0005.76%
Avoro Capital Advisors LLC 9,000,000$207,810,0003.58%
Ghost Tree Capital, LLC 600,000$13,854,0003.09%
SECTORAL ASSET MANAGEMENT INC 1,534,604$35,434,0002.50%
CM Management, LLC 90,000$2,078,0001.93%
Boxer Capital, LLC 2,325,000$53,684,0001.73%
Hood River Capital Management LLC 2,204,140$50,894,0001.68%
View complete list of AMICUS THERAPEUTICS INC shareholders